CURE – ETFS S&P Biotech ETF

Offshore chief executives of ASX-listed biotech companies are descending on Australia this month, looking to shore up support amid the sector-wide sell-off.
Locally, listed biotech companies take their lead from their US counterparts and, much like the Nasdaq Biotech Index, share price dives of 30 per cent-plus in the past six months have been common across the sector….